StreetAlpha.app
Home › Stocks › AZN

Astrazeneca PLC (AZN)

Healthcare
$182.24
▼ −1.00%
LAST CLOSE · NOV 17

AstraZeneca is a pharmaceutical company that develops and sells prescription medicines for cancer, heart, lung and other diseases. It last closed at $182.24 on Nov 17, down 1.00% on the day. AZN reports earnings on Tue, Feb 9, 2027. Over the past 90 days StreetAlpha recorded 5 whale options trades in AZN, 40% of them bullish and 60% bearish. In the past 30 days there were 5 dark pool prints totaling $2.9M, the largest $610K.

AI Auto Pilots
Is AZN in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$58.7B
+8.6% vs a year ago
Net income
$10.2B
+45.3% vs a year ago
Free cash flow
$11.8B
20.0% margin
Gross margin
81.9%
$48.1B gross profit
Balance sheet
Cash & equivalents
$5.7B
At Dec 31
Debt
$29.6B
At Dec 31
Shareholder equity
$48.7B
CEOPascal Soriot
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $37.4B$37.4BFY2021FY2022: $44.4B$44.4BFY2022FY2023: $45.8B$45.8BFY2023FY2024: $54.1B$54.1BFY2024FY2025: $58.7B$58.7BFY2025

From AZN's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Feb 24). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
Feb 9
2027 · Time not announced
Consensus EPS forecast
$2.32
$16.61B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated AZN in the past 90 days, not enough for a consensus
Average 12-month target
$198.00
▲ 8.6% upside

Based on 1 analyst who set a price target on AZN in the past 90 days. The average target is $198.00, with a high of $198.00 and a low of $198.00, compared with the last close of $182.24.

$152$169$185$201PAST 13 TRADING DAYS12-MONTH TARGETSHIGH $198AVG $198LOW $198Jul 9LAST CLOSE+12 MO$152$169$185$201PAST 13 DAYSTARGETSHIGH $198AVG $198LOW $198Jul 9LAST CLOSE+12 MO
Highest target$198.00
Average target$198.00
Lowest target$198.00
Latest rating changes
CICCInitiated
Aug 24Buy$198
DateFirmActionRatingPrice target
Aug 24CICCInitiatedBuy$198
Loading…

Technical Analysis

AZN · as of the Nov 17 close · updated after every close
Turning up

The stock is 1% above its 20 day and 7% above its 50 day average. It is 1% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 57). The nearest support is the swing low (Nov 6) at $181.20, and the nearest resistance the Pivot at $182.33.

Short trendBullish
Long trendNeutral
MomentumNeutral
StretchNormal
VolatilityHigh, 2.2%/day
Key levels
$212.7152 week high+16.7%
$186.12Swing high (Jun 5)+2.1%
$183.57Pivot R1+0.7%
$182.33Pivot+0.0%
$182.24Last close
$181.20Swing low (Nov 6)−0.6%
$180.99Pivot S1−0.7%
$180.7420 day average−0.8%
$180.14200 day average−1.2%
$169.6850 day average−6.9%
$169.11100 day average−7.2%
$153.4152 week low−15.8%
Indicators
RSI (14)57.36Middle of its rangeNeutral
MACD4.80Below its signal lineBearish
Stochastic59.8Middle of its rangeNeutral
ADX (14)25.1Trending up
Williams %R-52.6Oversold below −80, overbought above −20Neutral
CCI (20)15.8Oversold below −100, overbought above 100Neutral
Rate of change−0.9%Change over 10 sessionsBearish
ATR (14)$4.07Typical daily range, 2.2% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for AZN

What happened before

See how AZN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bearish2 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow AZN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How AZN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
5
Bullish
2
40%
Bearish
3
60%
Date span
Aug 27 – Nov 2
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
5
Notional
$2.9M
Largest print
$610K
Loading…

AZN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●676 buying vs 694 selling
  • ▼Shares held by funds -4.7%
  • ▼Funds holding -69
  • ▲Superinvestors: 5 added, 0 cut
  • ▲Put/call 4.27 to 0.43
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding1,4471,516−4.6%
In funds' top 104758−19.0%
Held by funds–––
New / increased138 / 538272 / 514−14.0%
Reduced / sold out513 / 181472 / 147+12.1%
Put/call ratio0.434.27−89.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AZN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AZN is in one of them and how their past AZN trades turned out.

AZN in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AZN in an article yet. Here's the latest on the wider market.

AZN Congress Trades

All congress trades →
Trades, 12 months
9
Buys
7
78%
Sells
2
22%
People
4
Last filed Jul 21
Who traded AZN · since 2017
Latest 5 filings of 53
$1K – $15KTraded Mar 31, 2026Filed Jul 21, 2026
$15K – $50KTraded Mar 30, 2026Filed Jul 21, 2026
$1K – $15KTraded Dec 8, 2025Filed Jan 13, 2026
$1K – $15KTraded Dec 18, 2025Filed Jan 12, 2026
$1K – $15KTraded Nov 19, 2025Filed Dec 15, 2025
PersonTypeAmountTradedFiledDelay
Alan ArmstrongHouseBuy$1K – $15KMar 31, 2026Jul 21, 2026112 d
Alan ArmstrongHouseBuy$15K – $50KMar 30, 2026Jul 21, 2026113 d
Julia LetlowR · LABuy$1K – $15KDec 8, 2025Jan 13, 202636 d
Gilbert CisnerosD · CABuy$1K – $15KDec 18, 2025Jan 12, 202625 d
Gilbert CisnerosD · CABuy$1K – $15KNov 19, 2025Dec 15, 202526 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Astrazeneca

AstraZeneca is a pharmaceutical company based in Cambridge that researches, develops and sells prescription medicines. Its work covers several therapy areas, including cancer, heart, kidney and metabolic disease, respiratory and immune conditions, rare diseases, and vaccines. Much of its research focuses on new treatments still in clinical trials, which it develops alone or with partners. Its medicines are aimed at patients and the healthcare providers who treat them.

Headquarters
Cambridge
Founded
1913